Table 1:
Demographic, sexual health, and PrEP uptake data from a regional sample of Latin American GSN app users in 2018–2019
| Variable | Total, n (%) n=718 |
|---|---|
| Age, years | |
| 18–25 | 189 (26.3) |
| 26–30 | 146 (20.3) |
| 31–40 | 213 (29.7) |
| 41+ | 170 (23.7) |
|
| |
| Country | |
| Chile a | 234 (32.6) |
| Colombia | 190 (26.5) |
| Argentina a | 127 (17.7) |
| Peru a | 60 (8.4) |
| Ecuador | 24 (3.3) |
| Costa Rica a | 24 (3.3) |
| Venezuela | 21 (2.9) |
| Uruguay | 17 (2.4) |
| Guatemala | 11 (1.5) |
| Paraguay | 10 (1.4) |
|
| |
| City Population Size b | |
| ≥ 500,000 | 594 (82.7) |
| < 500,000 | 102 (14.2) |
|
| |
| HIV Status c | |
| Negative | 614 (85.5) |
| Status Unknown | 104 (14.5) |
|
| |
| Chemsex d,e | 27 (3.8) |
|
| |
| STI testing f,g | 473 (65.9) |
|
| |
| STI diagnosis f,g | |
| Yes h | 62 (8.6) |
| Not sure | 26 (3.6) |
| No | 630 (87.7) |
|
| |
| PEP use f,h | 33 (4.6) |
|
| |
| PrEP eligible h | 91 (12.7) |
|
| |
| PrEP awareness | 518 (72.1) |
|
| |
| PrEP information source i | |
| Internet | 274 (52.9) |
| GSN/Dating applications | 94 (18.2) |
| Friends | 60 (11.6) |
| Doctor | 36 (7.0) |
| Other | 54 (10.4) |
|
| |
| PrEP use i | 29 (5.6) |
|
| |
| Intention to use PrEP j | |
| Agree | 157 (32.1) |
| Do not agree | 332 (67.9) |
Countries with partial or full adoption of PrEP policy; includes regulatory approval of PrEP medications and PrEP availability for eligible populations under national policy 6
Based on United Nations population data estimates for 2015;12 data unavailable for N=22 (3.1%) of reported cities
Respondents living with HIV (n=123) were removed from analysis; there were no questions pertaining to timing of recent HIV testing
Previous three months
Survey question specified the following drugs: Mephedrone, GHB/GBL, Ketamine, Methamphetamine. GHB and GBL stand for gamma hydroxybutyrate and gamma butyrolactone, respectively
Previous twelve months
Respondents were asked about sexually transmitted infections in general; no specific infection was listed
Those reporting PEP use and/or STI diagnosis in the previous 12 months were categorized as PrEP-eligible
Includes only those who had heard or PrEP, n=518
Includes only those who had heard of PrEP and were not currently taking PrEP, n=489
Abbreviations: PrEP (pre-exposure prophylaxis), GSN (geosocial networking), HIV (human immunodeficiency virus), STI (sexually transmitted infection), PEP (post-exposure prophylaxis)